article · The Egyptian Journal of Hospital Medicine
Background:Diabetic peripheral neuropathy (DPN) is the most frequent kind of neuropathy globally. DPN is one of the most prevalent and serious microvascular consequences of diabetes.Objective: To assess prevalence of DPN, its pattern, severity and associated risk factors in Benha City, Egypt. Patients and methods: This cross-sectional observational study was conducted on 500 diabetic patients (type 1 and type 2). All patients were subjected tocomplications of diabetes especially microvascular and macrovascular complications, diabetic foot and history of previous operations, physical examinations (general, neurological, sensory examination and Toronto clinical scoring system (TCSS)) and laboratory investigations (CBC, hemoglobin A1c (HbA1c), kidney function tests, liver function tests, serum thyroid-stimulating hormone and lipogram).Results: Body mass index (BMI), height, duration of diabetes, HbA1c, and thyroid-stimulating hormone (TSH) had a strong positive significant correlation with TCSS score (r=0.338, P< 0.001; r=0.335, P< 0.001; r=0.630, P< 0.001; r=0.806, P< 0.001; r=0.332, P< 0.001 respectively). Low-density lipoprotein-cholesterol (LDL-C) level and triglycerides level had no significant correlation with TCSS score (r= 0.015, P= 0.743; r= 0.074, P= 0.097 respectively). Conclusions: The primary risk factors include higher BMI, height, hard working, smoking, poor glycemic management, extended diabetes mellitus (DM), metformin use, chronic kidney disease (CKD), and an abnormal thyroid profile. After documenting these findings, a greater effort should be made to lower the frequency and severity of PDN in diabetic patients by education emphasising regular foot care, strict glucose control, and lifestyle adjustment.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejhm.2024.352199
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.